BRNS logo

BRNS
Barinthus Biotherapeutics PLC - ADR

160
Mkt Cap
$27.91M
Volume
1,780.00
52W High
$2.92
52W Low
$0.512
PE Ratio
-0.53
BRNS Fundamentals
Price
$0.6825
Prev Close
$0.6832
Open
$0.6627
50D MA
$0.6229
Beta
0.72
Avg. Volume
19,083.87
EPS (Annual)
-$1.64
P/B
0.42
Rev/Employee
$0.00
$32.11
Loading...
Loading...
News
all
press releases
Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders?
Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders? Are KW, BRNS, AFBI Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, May 12, 2026 Insiders may stand to receive...
PR Newswire
News Placeholder
More News
News Placeholder
Barinthus Biotherapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of Barinthus Biotherapeutics plc (the Company...
Business Wire
News Placeholder
Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders?
Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders? Are NSA, ULY, ESQ, BRNS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 16, 2026 Insiders may stand to...
PR Newswire
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--BRNS, SLAB, MCFT, and MPX
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--BRNS, SLAB, MCFT, and MPX $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--BRNS...
PR Newswire
News Placeholder
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) Upgraded to Buy: What Does It Mean for the Stock?
Barinthus Biotherapeutics PLC Sponsored ADR (BRNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
News Placeholder
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages BRNS, FITB, ADVM, HBAN Shareholders to Contact the Firm to...
PR Newswire
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-CMA, HFWA, BRNS, and FITB
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-CMA, HFWA, BRNS, and FITB $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-CMA...
PR Newswire
News Placeholder
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their...
PR Newswire
News Placeholder
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF...
PR Newswire
News Placeholder
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics
ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with...
PR Newswire
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available